The underlying eps is 12.8 : $112m mkt cap over underlying NPAT $8.7 (which excludes significant items)
A 40% increase would lead to a 9.2 PE
Given the contracting and cyclical nature of the company (albeit that it now has a few good years ahead) a PE of around 10 probably makes sense. If the growth outlook beyond FY22 becomes more certain then a 12 PE might apply. So I see the share price sitting around 45-55c for the next year.
- Forums
- ASX - By Stock
- Ann: FY21 Full Year Results Presentation
ACF
acrow limited
Add to My Watchlist
2.53%
!
$1.02

The underlying eps is 12.8 : $112m mkt cap over underlying NPAT...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.02 |
Change
0.025(2.53%) |
Mkt cap ! $312.5M |
Open | High | Low | Value | Volume |
99.0¢ | $1.02 | 99.0¢ | $448.9K | 447.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 8010 | $1.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.02 | 3548 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 8010 | 1.000 |
1 | 11929 | 0.995 |
1 | 5000 | 0.990 |
1 | 990 | 0.980 |
2 | 26544 | 0.970 |
Price($) | Vol. | No. |
---|---|---|
1.020 | 19000 | 2 |
1.030 | 9784 | 1 |
1.035 | 30000 | 1 |
1.050 | 27685 | 3 |
1.055 | 20098 | 2 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
ACF (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online